Cathepsin cysteine protease inhibitors
US7012075B2 · kind B2 · utility
38Cited by
12References
29Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 1, 2002 |
| Grant date | Mar 14, 2006 |
| Priority date | — |
| Expiry date | Sep 22, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.